Trial intelligence / Profile preview

Losartan for Airway Mucociliary Dysfunction in COPD

NCT02416102Phase 4Terminated

Sponsor
University of Miami
Start
Mar 2016
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of losartan in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by University of Miami. Started Mar 2016; status: terminated.

02

Drugs

losartan
03

Conditions

chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)

Beyond the preview

Go deeper on NCT02416102.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02416102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call